These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37961108)

  • 1. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease.
    Chakraborty A; Sreenivasmurthy SG; Miller W; Huai W; Biswas T; Mandal SM; Boscá L; Krishnan B; Ghosh G; Hazra T
    bioRxiv; 2024 Jul; ():. PubMed ID: 37961108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease.
    Chakraborty A; Sreenivasmurthy SG; Miller W; Huai W; Biswas T; Mandal SM; Boscá L; Krishnan B; Ghosh G; Hazra T
    Proc Natl Acad Sci U S A; 2024 Sep; 121(39):e2406308121. PubMed ID: 39298485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
    Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
    PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.
    Chakraborty A; Tapryal N; Venkova T; Mitra J; Vasquez V; Sarker AH; Duarte-Silva S; Huai W; Ashizawa T; Ghosh G; Maciel P; Sarkar PS; Hegde ML; Chen X; Hazra TK
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8154-8165. PubMed ID: 32205441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis.
    Chatterjee A; Saha S; Chakraborty A; Silva-Fernandes A; Mandal SM; Neves-Carvalho A; Liu Y; Pandita RK; Hegde ML; Hegde PM; Boldogh I; Ashizawa T; Koeppen AH; Pandita TK; Maciel P; Sarkar PS; Hazra TK
    PLoS Genet; 2015 Jan; 11(1):e1004749. PubMed ID: 25633985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription.
    Gao R; Chakraborty A; Geater C; Pradhan S; Gordon KL; Snowden J; Yuan S; Dickey AS; Choudhary S; Ashizawa T; Ellerby LM; La Spada AR; Thompson LM; Hazra TK; Sarkar PS
    Elife; 2019 Apr; 8():. PubMed ID: 30994454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific acetylation of polynucleotide kinase 3'-phosphatase regulates its distinct role in DNA repair pathways.
    Islam A; Chakraborty A; Sarker AH; Aryal UK; Pan L; Sharma G; Boldogh I; Hazra T
    Nucleic Acids Res; 2024 Mar; 52(5):2416-2433. PubMed ID: 38224455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models.
    Joachimiak P; Ciesiołka A; Kozłowska E; Świtoński PM; Figura G; Ciołak A; Adamek G; Surdyka M; Kalinowska-Pośka Ż; Figiel M; Caron NS; Hayden MR; Fiszer A
    BMC Biol; 2023 Feb; 21(1):17. PubMed ID: 36726088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific acetylation of polynucleotide kinase 3'-phosphatase (PNKP) regulates its distinct role in DNA repair pathways.
    Islam A; Chakraborty A; Sarker AH; Aryal UK; Sharma G; Boldogh I; Hazra T
    bioRxiv; 2023 Aug; ():. PubMed ID: 37645927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair.
    Kalasova I; Hailstone R; Bublitz J; Bogantes J; Hofmann W; Leal A; Hanzlikova H; Caldecott KW
    Nucleic Acids Res; 2020 Jul; 48(12):6672-6684. PubMed ID: 32504494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of SCA3 and implications for other polyglutamine diseases.
    McLoughlin HS; Moore LR; Paulson HL
    Neurobiol Dis; 2020 Feb; 134():104635. PubMed ID: 31669734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant studies of phosphofructo-2-kinases do not reveal an essential role of fructose-2,6-bisphosphate in the regulation of carbon fluxes in yeast cells.
    Müller S; Zimmermann FK; Boles E
    Microbiology (Reading); 1997 Sep; 143 ( Pt 9)():3055-3061. PubMed ID: 9308187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of a conserved site mutation in the DNA end processing enzyme PNKP leading to ataxia with oculomotor apraxia type 4 in humans.
    Islam A; Chakraborty A; Gambardella S; Campopiano R; Sarker AH; Boldogh I; Hazra T
    J Biol Chem; 2023 May; 299(5):104714. PubMed ID: 37061005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.
    Morozko EL; Smith-Geater C; Monteys AM; Pradhan S; Lim RG; Langfelder P; Kachemov M; Kulkarni JA; Zaifman J; Hill A; Stocksdale JT; Cullis PR; Wu J; Ochaba J; Miramontes R; Chakraborty A; Hazra TK; Lau A; St-Cyr S; Orellana I; Kopan L; Wang KQ; Yeung S; Leavitt BR; Reidling JC; Yang XW; Steffan JS; Davidson BL; Sarkar PS; Thompson LM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
    Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
    Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
    Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3.
    Zeng L; Wang B; Merillat SA; Minakawa EN; Perkins MD; Ramani B; Tallaksen-Greene SJ; Costa MDC; Albin RL; Paulson HL
    Neurobiol Dis; 2015 Oct; 82():281-288. PubMed ID: 26141599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
    Yalcin A; Clem BF; Imbert-Fernandez Y; Ozcan SC; Peker S; O'Neal J; Klarer AC; Clem AL; Telang S; Chesney J
    Cell Death Dis; 2014 Jul; 5(7):e1337. PubMed ID: 25032860
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.